Viewing Study NCT05038592


Ignite Creation Date: 2025-12-24 @ 3:21 PM
Ignite Modification Date: 2026-01-22 @ 4:58 AM
Study NCT ID: NCT05038592
Status: RECRUITING
Last Update Posted: 2025-07-29
First Post: 2021-06-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/II Study of Tagraxofusp in Combination With Decitabine for Patients With Myelomonocytic/Myeloproliferative Neoplasm and High Risk Myelodysplastic Syndromes
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myelomonocytic Leukemia View
None Chronic Myelomonocytic Leukemia-1 View
None Chronic Myelomonocytic Leukemia-2 View
None Myelodysplastic/Myeloproliferative Neoplasm View
Keywords: